Company Overview
About Uncommon Bio
Uncommon Bio (formerly Higher Steaks) is a UK-based biotechnology company that underwent a significant strategic pivot in 2024–2025, transitioning from cultivated meat production toward developing scalable biomanufacturing technologies for human therapeutic applications. Founded by Benjamina Bollag, the company was originally focused on developing cultivated pork products using cell culture and bioprocess engineering techniques. In 2025, Uncommon Bio's cultivated meat platform and associated intellectual property were acquired by Meatable, a Netherlands-based cultivated meat company — allowing Uncommon Bio to exit the food application space and redirect its biomanufacturing expertise toward the healthcare and therapeutics sector.
Business Model & Competitive Advantage
Uncommon Bio''s current focus is on applying its cellular agriculture and bioprocess engineering capabilities to therapeutic biomanufacturing challenges — leveraging the company''s expertise in cell line development, bioreactor scale-up, and manufacturing process design for applications in human health. The therapeutics biomanufacturing sector faces significant production bottlenecks for cell-based therapies, gene therapies, and biologics that share fundamental process engineering challenges with cultivated meat production: efficiently growing mammalian cells at scale in bioreactors under controlled conditions. This technology transfer from food to medicine represents a broader trend as cultivated meat companies pivot their bioengineering capabilities toward higher-margin therapeutic markets.
Competitive Landscape 2025–2026
As an early-stage company in active strategic transition, Uncommon Bio''s commercial profile and specific therapeutic program focus are evolving. The company represents an interesting case study in the transferability of cellular agriculture engineering capabilities to healthcare manufacturing — and positions itself at the intersection of precision fermentation, cell biology tooling, and therapeutic contract development and manufacturing (CDMO) markets as it develops its new strategic direction.
Key Differentiators
Emerging Innovator
Uncommon Bio is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Similar Brands
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Vivtex
Vivtex is an MIT Langer Laboratory spinout that has developed a drug delivery platform enabling oral administration of biologics — proteins, peptides, and other large molecules — that have historicall
Compare Uncommon Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Uncommon Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Uncommon Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Uncommon Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →